BridgeBio Pharma BBIO Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$729.89M-7.8% | -$732.94M-34.9% | -$805.69M-80.5% | -$785.01M-70.1% | -$676.8M-23.8% | ||
| $5.34M-7.4% | $5.43M-10.6% | $5.37M-14.7% | $5.51M-13.9% | $5.76M-10.7% | ||
| $140.38M+34.2% | $133.02M+38.9% | $128.51M+25.1% | $120.41M+22.7% | $104.63M+0.7% | ||
| -$443.95M— | -$445.91M— | -$584.82M— | -$655.81M— | —— | ||
| $1.17M+390% | $1.1M+17.6% | $1.11M-15.9% | $778K-51.8% | $238K-88.0% | ||
| —— | —— | —— | $23.63M-62.8% | $39.67M-38.5% | ||
| —— | —— | —— | —— | $48.28M— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | $837.01M— | $534.97M— | ||
| $339.28M— | -$111.1M— | $237.22M— | —— | —— | ||
| -$445.12M— | -$447.01M— | -$585.93M— | -$656.59M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does BridgeBio Pharma generate?
- BridgeBio Pharma (BBIO) generated -$444.0M in operating cash flow over the trailing twelve months.
- What is BridgeBio Pharma's free cash flow?
- After $1.2M of capital expenditures, BridgeBio Pharma's free cash flow was -$445.1M over the trailing twelve months, up 44.0% year over year.
- Where does BridgeBio Pharma's cash flow data come from?
- Every line is extracted from BridgeBio Pharma's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
